Synthesis and evaluation of some water-soluble prodrugs and derivatives of taxol with antitumor activity
- PMID: 1346275
- DOI: 10.1021/jm00079a019
Synthesis and evaluation of some water-soluble prodrugs and derivatives of taxol with antitumor activity
Abstract
The synthesis and evaluation of some 2'- and 7-amino acid derivatives of taxol (1) are reported. Reaction of taxol with N-protected amino acids gave 2'-N-protected amino acid esters of taxol. However, deprotection of the amino group and subsequent isolation of products were complex and only successful when formic acid was used to deprotect a t-BOC protecting group. Esterification of taxol using N,N-dialkylated amino acids gave 2'-amino acid esters of taxol, 2'-(N,N-dimethylglycyl)taxol (4) and 2'-[3-(N,N-diethylamino)propionyl]taxol as its methanesulfonic acid salt (5b), in good yield. The 7-derivatives, 7-(N,N-dimethylglycyl)taxol (9) and 7-L-alanyltaxol (12), were prepared by two alternate methods. In the first approach, the 2'-hydroxyl group was protected using the [(2,2,2-trichloro-ethyl)oxy]carbonyl, or troc, protecting group followed by the esterification of the 7-hydroxyl and subsequent deprotection of the amino and troc groups. In the second approach, taxol was allowed to react with more than 2 molar equiv of the N-protected amino acids or N,N-dialkylated amino acids to give 2',7-diamino acid esters of taxol. For the protected amino acids, the deprotection of the amino group followed by removal of the 2'-substituent gave the 7-amino acid esters of taxol. The methanesulfonic acid salts of both 2'- and 7-amino acid esters showed improved solubility ranging from 2 to greater than 10 mg/mL. The 7-derivatives were effective in promoting microtubule assembly in vitro while 2'-derivatives showed little in vitro activity. The derivatives 2'-(N,N-dimethylglycyl)taxol (4) and 2'-[3-(N,N-diethylamino)propionyl]taxol (5) inhibited proliferation of B16 melanoma cells to an extent similar to that of taxol, while the other derivatives were about 50% as cytotoxic. In a mammary tumor screen, 2'-[3-(N,N-diethylamino)propionyl]taxol showed the greatest antitumor activity compared to the other analogues. The lower activities of the 7-derivatives in inhibiting tumor growth and melanoma cell proliferation (although they were almost as active as taxol in inducing microtubule assembly in vitro) may be due to differences in drug uptake by the cells. The similar cytotoxic and antitumor activities of the 2'-analogues and taxol can be explained by their conversion to taxol or an active taxol metabolite. Therefore, the 2'-analogues appear to behave as prodrugs and have the potential to be developed as chemotherapeutic agents.
Similar articles
-
Synthesis of congeners and prodrugs. 3. Water-soluble prodrugs of taxol with potent antitumor activity.J Med Chem. 1989 Apr;32(4):788-92. doi: 10.1021/jm00124a011. J Med Chem. 1989. PMID: 2564894
-
Synthesis and evaluation of water-soluble docetaxel prodrugs-docetaxel esters of malic acid.Bioorg Med Chem. 2007 Sep 15;15(18):6323-30. doi: 10.1016/j.bmc.2007.04.002. Epub 2007 Apr 6. Bioorg Med Chem. 2007. PMID: 17624790
-
Biologically active taxol analogues with deleted A-ring side chain substituents and variable C-2' configurations.J Med Chem. 1991 Mar;34(3):1176-84. doi: 10.1021/jm00107a042. J Med Chem. 1991. PMID: 1672157
-
Synthesis and biological evaluation of butanoate, retinoate, and bis(2,2,2-trichloroethyl)phosphate derivatives of 5-fluoro-2'-deoxyuridine and 2',5-difluoro-2'-deoxyuridine as potential dual action anticancer prodrugs.Arch Pharm (Weinheim). 1999 Aug;332(8):286-94. doi: 10.1002/(sici)1521-4184(19998)332:8<286::aid-ardp286>3.0.co;2-9. Arch Pharm (Weinheim). 1999. PMID: 10489539 Review.
-
Taxol: a novel investigational antimicrotubule agent.J Natl Cancer Inst. 1990 Aug 1;82(15):1247-59. doi: 10.1093/jnci/82.15.1247. J Natl Cancer Inst. 1990. PMID: 1973737 Review.
Cited by
-
Impact of Dendrimers on Solubility of Hydrophobic Drug Molecules.Front Pharmacol. 2017 May 16;8:261. doi: 10.3389/fphar.2017.00261. eCollection 2017. Front Pharmacol. 2017. PMID: 28559844 Free PMC article. Review.
-
A Novel Paclitaxel Derivative for Triple-Negative Breast Cancer Chemotherapy.Molecules. 2023 Apr 23;28(9):3662. doi: 10.3390/molecules28093662. Molecules. 2023. PMID: 37175072 Free PMC article.
-
Enhanced oral bioavailability of paclitaxel by coadministration of the P-glycoprotein inhibitor KR30031.Pharm Res. 2003 Jan;20(1):24-30. doi: 10.1023/a:1022286422439. Pharm Res. 2003. PMID: 12608532
-
Synthesis, Biological Evaluation and Low-Toxic Formulation Development of Glycosylated Paclitaxel Prodrugs.Molecules. 2018 Dec 5;23(12):3211. doi: 10.3390/molecules23123211. Molecules. 2018. PMID: 30563132 Free PMC article.
-
Prevention of paclitaxel-induced neuropathy by formulation approach.J Control Release. 2019 Jun 10;303:109-116. doi: 10.1016/j.jconrel.2019.04.013. Epub 2019 Apr 11. J Control Release. 2019. PMID: 30981814 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources